 Secondary myelodysplastic syndrome therapy osteogenic sarcoma girl nonmetastatic osteogenic sarcoma treatment doxorubicin methotrexate cisplatin cyclophosphamide bleomycin dactinomycin unexplained persistent pancytopenia completion chemotherapy Twenty-three months initial diagnosis osteosarcoma evaluation bone marrow pattern consistent diagnosis refractory anemia excess blasts karyotype analysis characteristic findings therapy-related myelodysplasia loss chromosomes deletions Bone marrow transplantation human leukocyte antigen HLA -compatible donor months diagnosis primary malignancy unproven agents patient responsible myelodysplastic syndrome careful follow-up osteosarcoma patients agents